文献速递产科母胎医学

妊娠期及产后COVID-19女性不良结局的临床危险因素:一项序贯、前瞻性Meta分析

Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis.
PubMed 文献 · Am J Obstet Gynecol · 2022-08-24

该序贯前瞻性Meta分析纳入33个国家和地区的21977例妊娠期或产后SARS-CoV-2感染病例,评估多种临床危险因素与疾病严重程度、母体并发症、新生儿死亡及不良出生结局的关联。合并症、HIV感染、孕前体重不足、孕前肥胖及贫血均与不良结局风险升高相关。作者认为除将孕妇视为高危人群外,应对具有这些额外危险因素的孕妇给予预防和治疗的优先关注。

要点

  • 合并症(孕前糖尿病、高血压、心血管疾病)与COVID-19严重程度及不良妊娠结局风险升高相关。
  • HIV感染、孕前体重不足及贫血为较少被认识的危险因素,与ICU入住等风险升高相关。
  • 孕前肥胖与ICU入住、通气、重症监护及肺炎风险升高相关。

核心结论

  • 合并糖尿病、高血压和心血管疾病的孕妇COVID-19相关严重结局、母体并发症及不良出生结局风险增加。
  • HIV感染、孕前体重不足和贫血也被识别为危险因素。
  • 作者认为应对具有这些额外危险因素的孕妇给予预防和治疗的优先关注。

研究设计与样本

  • 序贯、前瞻性Meta分析,自2020年3月起通过专业研究网络邀请研究 investigators 参加。
  • 纳入标准为在 defined catchment area 内连续招募至少25例妊娠期COVID-19病例的研究。
  • 纳入21项参与研究的个体患者数据,覆盖33个国家和地区,共21977例妊娠期或产后SARS-CoV-2感染病例。
  • 采用两阶段Meta分析生成有和无各危险因素者不良结局的绝对和相对风险合并估计。

主要发现

  • 有合并症(孕前糖尿病、高血压、心血管疾病)者与无合并症者相比,COVID-19严重程度及不良妊娠结局(胎死宫内、早产、低出生体重)风险更高。
  • HIV感染者入住ICU的可能性为1.74倍(95%CI 1.12-2.71)。
  • 孕前体重不足者入住ICU的相对风险为5.53(95%CI 2.27-13.44),通气的相对风险为9.36(95%CI 3.87-22.63),妊娠相关死亡的相对风险为14.10(95%CI 2.83-70.36)。
  • 孕前肥胖者入住ICU的相对风险为1.81(95%CI 1.26-2.60),通气的相对风险为2.05(95%CI 1.20-3.51),任何重症监护的相对风险为1.89(95%CI 1.28-2.77),肺炎的相对风险为1.66(95%CI 1.18-2.33)。
  • 贫血孕妇入住ICU的相对风险为1.63(95%CI 1.25-2.11),死亡的相对风险为2.36(95%CI 1.15-4.81)。

临床怎么用

  • 作者认为,尽管孕妇已被视为高危人群,应对具有合并症、HIV感染、孕前体重不足、孕前肥胖或贫血等额外危险因素的孕妇给予预防和治疗的优先关注。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This sequential, prospective meta-analysis sought to identify risk factors among pregnant and postpartum women with COVID-19 for adverse outcomes related to disease severity, maternal morbidities, neonatal mortality and morbidity, and adverse birth outcomes. DATA SOURCES: We prospectively invited study investigators to join the sequential, prospective meta-analysis via professional research networks beginning in March 2020. STUDY ELIGIBILITY CRITERIA: Eligible studies included those recruiting at least 25 consecutive cases of COVID-19 in pregnancy within a defined catchment area. METHODS: We included individual patient data from 21 participating studies. Data quality was assessed, and harmonized variables for risk factors and outcomes were constructed. Duplicate cases were removed. Pooled estimates for the absolute and relative risk of adverse outcomes comparing those with and without each risk factor were generated using a 2-stage meta-analysis. RESULTS: We collected data from 33 countries and territories, including 21,977 cases of SARS-CoV-2 infection in pregnancy or postpartum. We found that women with comorbidities (preexisting diabetes mellitus, hypertension, cardiovascular disease) vs those without were at higher risk for COVID-19 severity and adverse pregnancy outcomes (fetal death, preterm birth, low birthweight). Participants with COVID-19 and HIV were 1.74 times (95% confidence interval, 1.12-2.71) more likely to be admitted to the intensive care unit. Pregnant women who were underweight before pregnancy were at higher risk of intensive care unit admission (relative risk, 5.53; 95% confidence interval, 2.27-13.44), ventilation (relative risk, 9.36; 95% confidence interval, 3.87-22.63), and pregnancy-related death (relative risk, 14.10; 95% confidence interval, 2.83-70.36). Prepregnancy obesity was also a risk factor for severe COVID-19 outcomes including intensive care unit admission (relative risk, 1.81; 95% confidence interval, 1.26-2.60), ventilation (relative risk, 2.05; 95% confidence interval, 1.20-3.51), any critical care (relative risk, 1.89; 95% confidence interval, 1.28-2.77), and pneumonia (relative risk, 1.66; 95% confidence interval, 1.18-2.33). Anemic pregnant women with COVID-19 also had increased risk of intensive care unit admission (relative risk, 1.63; 95% confidence interval, 1.25-2.11) and death (relative risk, 2.36; 95% confidence interval, 1.15-4.81). CONCLUSION: We found that pregnant women with comorbidities including diabetes mellitus, hypertension, and cardiovascular disease were at increased risk for severe COVID-19-related outcomes, maternal morbidities, and adverse birth outcomes. We also identified several less commonly known risk factors, including HIV infection, prepregnancy underweight, and anemia. Although pregnant women are already considered a high-risk population, special priority for prevention and treatment should be given to pregnant women with these additional risk factors.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Smith ER, Oakley E, Grandner GW, et al. Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis. Am J Obstet Gynecol. 2022. PMID: 36027953. doi:10.1016/j.ajog.2022.08.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。